APA

Deshpande V., Krishnan R., Philip S., Faludi I., Ponnusamy T., Thota L. N. R., Endresz V., Lu X., Kakkar V. V. & Mundkur L. A. (20170217). Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) mice. : Cardiovascular therapeutics.

Chicago

Deshpande Vrushali, Krishnan Rameshkumar, Philip Sheena, Faludi Ildiko, Ponnusamy Thiruvelselvan, Thota Lakshmi Narasimha Rao, Endresz Valeria, Lu Xinjie, Kakkar Vijay V and Mundkur Lakshmi A. 20170217. Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) mice. : Cardiovascular therapeutics.

Harvard

Deshpande V., Krishnan R., Philip S., Faludi I., Ponnusamy T., Thota L. N. R., Endresz V., Lu X., Kakkar V. V. and Mundkur L. A. (20170217). Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) mice. : Cardiovascular therapeutics.

MLA

Deshpande Vrushali, Krishnan Rameshkumar, Philip Sheena, Faludi Ildiko, Ponnusamy Thiruvelselvan, Thota Lakshmi Narasimha Rao, Endresz Valeria, Lu Xinjie, Kakkar Vijay V and Mundkur Lakshmi A. Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) mice. : Cardiovascular therapeutics. 20170217.